Global innovative medical firms pick KL as regional hub

People power: Roach says AstraZeneca invests substantially to upskill and develop its people.

GLOBAL medical technology and pharmaceutical firms are turning to Malaysia as their investment destination, as they chart their mid-to-long term growth strategy across the region.

For biopharmaceutical company AstraZeneca, the focus going forward will be on achieving growth through a science-led innovation strategy, its country president and managing director Dr Sanjeev Panchal said.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Business News

China's new trading rules not designed to kill 'flash boys', lobby group says
Dollar hits 10-month high as US yields spike, yen slides
UK's ASOS sees profit at bottom end of guidance as turnaround stutters
Oil prices slip as high interest rate outlook outweighs tight supply
GlobalFoundries opens new hub facility in Penang
US yields march higher, Asia stocks sag amid Fed angst
Singapore Aug manufacturing output dives 12% y/y, more than expected
China Evergrande shares tumble for second day after unit misses bond payment
TNB expects RM7bil recovery from ICPT in 1H24 amid favourable fuel price trends
Malaysia's producer price index declines to -1.8% in August 2023

Others Also Read